Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 2 | Mind Blowing Facts

Datadog Is A Top Observability Player Leveraging Its Scale, Analysts Hail Company After 5th Dash Conference

Datadog, Inc (NASDAQ: DDOG) held its 5th Dash Conference over two days in New York, unveiling over a dozen new products and features.

Analysts Cut Price Targets On Splunk After Q2 Performance, Lower ARR Outlook

Analysts Cut Price Targets On Splunk After Q2 Performance, Lower ARR Outlook

Splunk Inc (NASDAQ: SPLK) clocked 32% revenue gro

Needham Sees Dynamics Favoring Datadog

Needham Sees Dynamics Favoring Datadog

Needham analyst Mike Cikos spoke to Datadog, Inc (NASDAQ: DDOG) to recap the ability to sustain growth in a challenging economy and a deeper dive into the consumption elements of Datadog's revenue model.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Here's Why Analysts Had Mixed Opinions On C3.ai Post Q4 Results

Analyst opinions remained mixed about C3.ai, Inc (NYSE:AI) following its dismal FY23 guidance despite a Q4 beat. Piper Sandler analyst Arvind Ramnani downgraded C3.ai from Overweight to Neutral and slashed the price target from $28 to $15. The re-rating reflected lackluster guidance triggered by enterprise spending softness, slower customer growth, and a dismal demand. Ramnani noted the…

Read How Analysts Reacted To MongoDB Post Q1 Earnings Beat

Analysts appreciated MongoDB, Inc's (NASDAQ:MDB) Q1 beat but cut the price target to reflect macro headwinds. Needham analyst Mike Cikos maintained MongoDB with a Buy rating and lowered the price target from $362 to $310. The price target change reflected the declines in the broader stock market. Cikos acknowledged MongoDB's strong 1QF23 feat outperforming guidance and expectations.…

Read How Analysts Reacted To Alteryx's Q4 Results

Analysts had mixed opinions on Alteryx Inc (NYSE:AYX) post Q4 beat. Alteryx is a software company that provides self-service data analytics software. Oppenheimer analyst Ittai Kidron lowered the firm's price target on Alteryx to $85 from $105 (62.9% upside) to reflect multiple realignments while keeping an Outperform rating on the shares. The analyst notes Alteryx's Q4…

1 2

People

Gregg Moskowitz

Blair Abernethy

Patrick Colville

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Canaccord Genuity

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play